Insider Transactions in Q4 2021 at Lineage Cell Therapeutics, Inc. (LCTX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Brian M Culley President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,343
-6.57%
|
$10,686
$2.45 P/Share
|
|
Dec 31
2021
|
Brian M Culley President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,450
+15.96%
|
-
|
|
Dec 29
2021
|
Gary S. Hogge SVP,Clinical & Medical Affairs |
SELL
Open market or private sale
|
Direct |
37,695
-62.27%
|
$75,390
$2.47 P/Share
|
|
Dec 29
2021
|
Gary S. Hogge SVP,Clinical & Medical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
9,250
+19.7%
|
$0
$0.69 P/Share
|
|
Dec 28
2021
|
Gary S. Hogge SVP,Clinical & Medical Affairs |
SELL
Open market or private sale
|
Direct |
501,588
-94.63%
|
$1,003,176
$2.45 P/Share
|
|
Dec 28
2021
|
Gary S. Hogge SVP,Clinical & Medical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
501,588
+31.32%
|
$501,588
$1.31 P/Share
|